How it all started

The interest in finding new formulas for biotechnological research and discovering new products moved a select group of experts to come together in the 90s.

Read our history

About COVID19

Given the exceptional situation for COVID-19 worldwide, we want to convey to you that the entire team at Hartington Pharmaceutical is working to guarantee the best possible service so that the impact on our customers is as little as possible.

We have taken all the containment measures recommended by the health authorities in order to guarantee the well-being of our human team and, at the same time, ensure the proper functioning and continuity of our services.

All our team is operational and available, to assist you through this same website, our usual phone and email: This email address is being protected from spambots. You need JavaScript enabled to view it. and +34 93 221 23 71.

If you need to contact us urgently, you can do it by phone in the following areas:

Pharmacovigilance:

Dr. Jordi Relats: +34 670 295 084
Ms. Marta Riba: +34 673 912 482

General:

Ms. Andrea Cozza: +34 605 322 969

We hope that the situation is resolved as soon as possible and we send a big hug and a fast recovery to all the people affected by such a terrible virus.

Hartington Group

about hartington pharma

Our principal motivation is to cover human needs, developing new products to treat highly prevalent diseases that are unsatisfactorily treated by existing medicines, and which have an enormous socio-sanitary impact.

Read more about us